FDA Approves Zoryve Cream for Plaque Psoriasis in Children as Young as 2 Years
The FDA has approved Arcutis Biotherapeutics' steroid-free Zoryve (roflumilast 0.3%) cream for…
FDA Grants Accelerated Approval to BMS for First-in-Class CELMoD Multiple Myeloma Therapy Zenbexus
The FDA has granted accelerated approval to Bristol Myers Squibb's Zenbexus (iberdomide),…